TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Merck Life Science AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
188,894
|
197,791
|
167,685 |
Financial expenses |
452
|
543
|
57 |
Earnings before taxes |
11,397
|
18,894
|
12,130 |
Total assets |
99,716
|
97,277
|
74,474 |
Current assets |
99,667
|
96,899
|
73,905 |
Current liabilities |
22,303
|
28,710
|
20,605 |
Equity capital |
77,413
|
68,567
|
53,869 |
- share capital |
12,500
![]() |
12,500
![]() |
12,500 |
Employees (average) |
12
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.6%
|
70.5%
|
72.3% |
Turnover per employee |
16,483
|
18,632 | |
Profit as a percentage of turnover |
6.0%
|
9.6%
|
7.2% |
Return on assets (ROA) |
11.9%
|
20.0%
|
16.4% |
Current ratio |
446.9%
|
337.5%
|
358.7% |
Return on equity (ROE) |
14.7%
|
27.6%
|
22.5% |
Change turnover |
-8,897
|
30,106
|
24,912 |
Change turnover % |
-4%
|
18%
|
17% |
Chg. No. of employees |
3
|
-1 | |
Chg. No. of employees % |
33%
|
-10% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.